Skip to main content
Clinical Trials/NCT02665507
NCT02665507CompletedPhase 2

Evaluation of the Efficacy of Light Therapy for the Treatment of Back Pain in Pilots

Hebrew University of Jerusalem1 site in 1 country42 target enrollmentStarted: March 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
42
Locations
1
Primary Endpoint
Time to reach minimal important change in pain level by visual analog scale (VAS)

Study Overview

Brief Summary

Back pain is a common complaint among pilots. Current treatments include physiotherapy and chiropractic manipulations. Low-level laser irradiation (LLLI) in the visible to near-infrared range was shown to reduce neck and low back pain.

The purpose of the study is to evaluate the efficacy of Light Therapy for treatment of back pain in pilots.

Detailed Description

Background: Lumbar spine disorders are common conditions in pilots of various aircraft with etiology related to sub-optimal ergonomics, exposure to G-forces, the weight of the head gear and exposure to extensive vibrations. Current treatments include physiotherapy and chiropractic manipulations. Low-level laser irradiation (LLLI) is a non-ionizing, non-thermal irradiation within the visible to near infrared range of the light spectrum. LLLI has been used widely for alleviation of pain in inflammatory processes and acceleration of wound healing. A variety of clinical studies show that LLLT in the near infrared range may be useful in the treatment of back pain.

Objective

To evaluate the efficacy of Light Therapy for treatment of back pain in pilots.

Study design: Prospective, randomized, controlled double blind. Volunteers will receive biweekly physiotherapy treatment for 3 weeks. In addition to the physiotherapy treatment, half the volunteers will receive light therapy and half sham irradiation. Study evaluations will include physical examination by an orthopedic surgeon, subjective pain level by visual analogue scale, validated low back functional questionnaires, a generic functional questionnaire, and patient satisfaction scores. Volunteers will be invited for evaluations at 1 and 3 months after the final treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pilot (current)
  • Level of pain - moderate to severe low back pain (≥40 on the pain VAS)

Exclusion Criteria

  • Low back pain due to non-traumatic etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, cauda equinal syndrome).
  • Recent (up to 1 year) history of trauma
  • Current chronic pain other than low back pain
  • Physical disability that prevents the patient to lie down/get up

Outcomes

Primary Outcomes

Time to reach minimal important change in pain level by visual analog scale (VAS)

Time Frame: within 4 months

Secondary Outcomes

  • Change in pain level by VAS after 3 weeks compared to baseline (before treatment)(3 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lilach Gavish

Study Director

Hebrew University of Jerusalem

Study Sites (1)

Loading locations...

Similar Trials